Market revenue in 2023 | USD 11.5 million |
Market revenue in 2030 | USD 28.6 million |
Growth rate | 13.9% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Irreversible Electroporation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 44.35% in 2023. Horizon Databook has segmented the Indonesia tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Indonesia tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into Indonesia tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account